Mechanism-Based Markers of Drug-Induced Liver Injury to Improve the Physiological Relevance and Predictivity of In Vitro Models
Year: 2015
Type: article
Source: Applied In Vitro Toxicology
Authors: Chris Goldring, Alan Norris, Neil Kitteringham, Michael D. Aleo, Daniel J. Antoine, James Heslop, Brett A. Howell, Magnus Ingelman-Sundberg, Richard Kia, Laleh Kamalian, Sarah Koerber, Jean-Claude Martinou, Amy Mercer, Jonathan Moggs, Dean J. Naisbitt, Christopher Powell, James Sidaway, Rowena Sison-Young, Jan Snoeys, Bob van de Water, Paul B. Watkins, Richard J. Weaver, Armin Wolf, Fang Zhang, B. Kevin Park
Institutions: University of Liverpool, Pfizer (United States), University of North Carolina at Chapel Hill, Karolinska Institutet, University of Geneva, Novartis (Switzerland), Novartis Institutes for BioMedical Research, GlaxoSmithKline (United Kingdom), AstraZeneca (United Kingdom), Janssen (Belgium), Leiden University, Institut de Recherches Internationales Servier (France)
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
Funder: Medical Research Council
Award: G8401121362
OpenAlex ID: W1822491899